Back to Resource Center

Advancing Vaginal Health Products: Addressing BV and STI/HIV Prevention Through Next-Generation MPTs

Advancing Vaginal Health Products: Addressing BV and STI/HIV Prevention Through Next-Generation MPTs

February 2026

Click to view Webinar

Click for full info +

This session of IMPT’s Let’s Talk MPTs webinar series explores how next-generation multipurpose prevention technologies (MPTs) can integrate BV management with STI/HIV prevention in single, user-controlled products. Bacterial vaginosis (BV) significantly increases vulnerability to HIV and other sexually transmitted infections (STIs), yet remains under-addressed in prevention strategies.

Presenters:
Ishita Shah, PhD (Matrubials, Inc.) discussed antimicrobial peptides for treatment/prevention of BV and other STIs; and
Laurel Lagenaur, PhD (Osel Inc.) presented on live bacterial therapeutics for BV and HIV/STI prevention; and
Jen Balkus, PhD, MPH (University of Washington | Public Health Seattle & King County) framed the public health link between BV and infection risk.

Moderator:
Bethany Young Holt PhD, MPH Executive Director of the Initiative for Multipurpose Prevention Technologies (IMPT) | CAMI Health.

View webinar recording

Download presentations:

Dr. Jen Balkus – Bacterial vaginosis and HIV/STIs: The role of MPTs?

Dr. Ishita Shah – Antimicrobial Peptides for Treatment/Prevention of Bacterial Vaginosis and other STIs

Dr Laurel Lagenaur – Live Biotherapeutics to Modify the Vaginal Microbiota for Women’s Health


Full Info:


Resource Type:

Resource
Webinar

Authors: Jen Balkus PhD, MPH (University of Washington | Public Health Seattle & King County), Ishita Shah PhD (Matrubials Inc.), Laurel Lagenaur PhD (Osel Inc.) and the IMPT.

URL of resource:

https://youtu.be/mRohITNnJcs

Back to Resource Center